Affiliation:
1. School of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, China
2. Guangxi Key Laboratory of Marine Drugs, Institute of Marine Drugs, Guangxi University of Chinese Medicine, Nanning 530200, China
Abstract
The Mycobacterium tuberculosis (MTB) infection causes tuberculosis (TB) and has been a long-standing public-health threat. It is urgent that we discover novel antitubercular agents to manage the increased incidence of multidrug-resistant (MDR) or extensively drug-resistant (XDR) strains of MTB and tackle the adverse effects of the first- and second-line antitubercular drugs. We previously found that gliotoxin (1), 12, 13-dihydroxy-fumitremorgin C (2), and helvolic acid (3) from the cultures of a deep-sea-derived fungus, Aspergillus sp. SCSIO Ind09F01, showed direct anti-TB effects. As macrophages represent the first line of the host defense system against a mycobacteria infection, here we showed that the gliotoxin exerted potent anti-tuberculosis effects in human THP-1-derived macrophages and mouse-macrophage-leukemia cell line RAW 264.7, using CFU assay and laser confocal scanning microscope analysis. Mechanistically, gliotoxin apparently increased the ratio of LC3-II/LC3-I and Atg5 expression, but did not influence macrophage polarization, IL-1β, TNF-a, IL-10 production upon MTB infection, or ROS generation. Further study revealed that 3-MA could suppress gliotoxin-promoted autophagy and restore gliotoxin-inhibited MTB infection, indicating that gliotoxin-inhibited MTB infection can be treated through autophagy in macrophages. Therefore, we propose that marine fungi-derived gliotoxin holds the promise for the development of novel drugs for TB therapy.
Funder
Guangdong Marine Economy Development Special Project
Natural Science Foundation of Guangdong Province
Key-Area Research and Development Program of Guangdong Province
Special Fund for Bagui Scholars of Guangxi
National Natural Science Foundation of China
Scientific Research Foundation of Guangxi University of Chinese Medicine
Subject
Drug Discovery,Pharmacology, Toxicology and Pharmaceutics (miscellaneous),Pharmaceutical Science
Reference41 articles.
1. Hameed, H.M.A., Islam, M.M., Chhotaray, C., Wang, C., Liu, Y., Tan, Y.J., Li, X.J., Tan, S.Y., Delorme, V., and Yew, W.W. (2018). Molecular targets related drug resistance mechanisms in MDR-, XDR-, and TDR-Mycobacterium tuberculosis strains. Front. Cell Infect. Microbiol., 8.
2. Mycobacterium tuberculosis infection of host cells in space and time;Bussi;FEMS Microbiol. Rev.,2019
3. Natural products as sources of new drugs over the nearly four decades from 01/1981 to 09/2019;Newman;J. Nat. Prod.,2020
4. Antimycobacterial metabolites from marine invertebrates;Daletos;Arch. Pharm.,2016
5. Antituberculosis compounds from a deep-sea-derived fungus Aspergillus sp. SCSIO Ind09F01;Luo;Nat. Prod. Res.,2017
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献